(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Most loved Fish Dish: What's Your Sea Pleasure? - 2Witness the elegance of the cosmic butterfly in a remarkable telescope photo
- 3Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- 4Artemis II astronauts arrive at Florida launch site for first moon trip in 53 years
- 5The breakout star of NASA's Artemis 2 moon mission isn't an astronaut — it's the space toilet
- The Best 10 Innovation Advancements of the Year
- A whale stranded at a Baltic Sea resort has swum off a sandbank. But it isn't safe yet
- Vote in favor of Your #1 4\u00d74 SUVs
- Best Food Truck Cooking: Decision in favor of Your Number one!
- She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- 15 Preposterous Cosplay Ensembles That Will Blow You Away
- Scientists uncover an ant assassination scheme that helps a parasitic queen rise to power
- Curl Up With Some Hot Chocolate And Watch Mighty Car Mods Explore Japan In A Honda City Turbo II
- Governments take targeted action as fuel prices hit retail
